# US 2005/0240247 A1 · Fractionated light PDT therapy for posterior eye disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0240247 A1
- Document ID: US20050240247A1
- Status: Published application
- Kind: A1
- Application number: 11/089,944
- Filed: 2005-03-25
- Published: 2005-10-27
- Earliest claimed: 2004-04-22
- Assignees: Light Sciences Oncology, Inc.
- Inventors: Brian McIlroy; Gregory Heacock; Paula Mahoney; Andrew Hamilton
- Web page: https://patentgrep.com/patent/US20050240247A1

## CPC

- A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent}
- A61N 2005/0651: {Diodes}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A method and system directs therapeutic light of a first wavelength to a patient's eye to excite a photosensitizing agent for PDT during a series of discrete periods of time that are separated by non-therapeutic intervals. Diagnostic light of a second wavelength can be directed to the eye during at least a portion of one or more of the non-therapeutic intervals to allow a physician to see the affect of the therapy.

## Claims

### Claim 1

A method for treating and/or diagnosing a disease of a patient's eye that has been rendered photosensitive by the administration to the patient of a photosensitizing agent comprising:
directing to the patient's eye for a first predetermined period of time light of a first wavelength or waveband for exciting the photosensitizing agent in the eye;
stopping the direction of light of the first wavelength or waveband to the eye for a second predetermined period of time; and
resuming the direction of light of the first wavelength or waveband to the patient's eye after the second period of time.

### Claim 2 (depends on 1)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 1 wherein the first period of time is sufficient to cause a therapeutic PDT affect.

### Claim 3 (depends on 1)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 1 wherein the second period of time is at least ten seconds.

### Claim 4 (depends on 3)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 3 wherein the second period of time is not greater than forty seconds.

### Claim 5 (depends on 1)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 1 wherein the light of the first wavelength is therapeutic light for exciting the photosensitizing agent to undergo a photochemical interaction with oxygen.

### Claim 6 (depends on 5)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 5 wherein the second period of time is selected to allow eye tissue to re-oxygenate after the first period of time.

### Claim 7 (depends on 1)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 1 including directing to the patient's eye light of a second wavelength or waveband during at least a portion of the second period of time.

### Claim 8 (depends on 7)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 7 wherein the second wavelength of light is selected to excite photosensitive agent in the eye that is different than the photosensitive agent excited by the first wavelength of light.

### Claim 9

A method for treating and/or diagnosing a disease of a patient's eye that has been rendered photosensitive by the administration to the patient of a photosensitizing agent comprising:
directing to the patient's eye for a first period of time therapeutic light of a first energy level for exciting the administered photosensitizing agent to undergo a photochemical interaction with oxygen;
reducing, for a second predetermined period of time following the first period of time, the energy level of therapeutic light directed to the eye to a level that allows the eye to re-oxygenate; and
resuming the direction of light of the first energy level after the second period of time.

### Claim 10 (depends on 9)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 9 wherein the first period of time is about 40 seconds.

### Claim 11 (depends on 9)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 9 wherein the second period of time is at least ten seconds.

### Claim 12 (depends on 11)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 11 wherein the second period of time is not greater than forty seconds.

### Claim 13 (depends on 9)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 9 wherein the therapeutic light has a waveband centered about a wavelength of 664 mn.

### Claim 14 (depends on 9)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 9 including directing to the patient's eye diagnostic light during at least a portion of the second period of time, the diagnostic light exciting a second, photosensitive agent.

### Claim 15 (depends on 14)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 14 wherein the diagnostic light has a wavelength of about 485 nm.

### Claim 16

A method for treating and/or diagnosing a disease of a patient's eye that has been rendered photosensitive by the administration to the patient of a photosensitizing agent comprising:
directing to the patient's eye for a first predetermined period of time therapeutic light of a first wavelength or waveband for exciting a first photosensitizing agent;
directing to the patient's eye for a second predetermined period of time diagnostic light of a second wavelength or waveband for exciting a second photosensitizing agent, the diagnostic light being directed to the eye at a time after the end of the first period of time; and
resuming the direction of the therapeutic light to the patient's eye at a time after the end of the second period of time.

### Claim 17 (depends on 16)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 16 wherein the second photosensitizing agent includes a fluorescent dye.

### Claim 18 (depends on 17)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 17 including passing light of a third wavelength emitted by the excited fluorphore so that the light of the third wavelength can be seen by an observer and filtering other wavelengths of light so that they are not observed.

### Claim 19

A method for treating and/or diagnosing a disease of a patient's eye comprising:
administering a photosensitizing agent to a patient, the photosensitizing agent being absorbed in targeted eye tissue; and
directing therapeutic light to a patient's eye to excite the photosensitizing agent in the targeted tissue during a series of discrete periods of time that are separated by non-therapeutic intervals.

### Claim 20 (depends on 19)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 19 including administering a fluorescent agent to the eye; and directing, during at least a portion of one of the non-therapeutic interval, diagnostic light to the patient's eye to excite the fluorescent agent.

### Claim 21 (depends on 20)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 20 including passing light of a third wavelength emitted by the excited fluorphore so that the light of the third wavelength can be seen by an observer and filtering other wavelengths of light so that they are not observed.

### Claim 22 (depends on 20)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 20 wherein the therapeutic light has a waveband centered approximately about 664 nm.

### Claim 23 (depends on 20)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 20 wherein the diagnostic light has a wavelength of about 485 nm.

### Claim 24 (depends on 21)

A method for treating and/or diagnosing a disease of a patient's eye as recited in claim 21 wherein the wavelength of the light emitted by the fluorphore and passed for observation is about 530 nm.

### Claim 25

A system for directing light to an eye to which at least one photosensitizing agent has been administered comprising:
a source of therapeutic light of a first wavelength or waveband, the therapeutic light source being controlled to emit the therapeutic light during a series of discrete periods of time that are separated by non-therapeutic intervals;
a partial reflector for reflecting the therapeutic light of the first wavelength or waveband towards an eye and passing light of other wavelengths therethrough; and
a source of diagnostic light of a second wavelength, the diagnostic light being directed to the patient's eye during at least a portion of one of the non-therapeutic intervals.

### Claim 26 (depends on 25)

A system as recited in claim 25 wherein the source of therapeutic light is a light emitting diode having a waveband centered about 664 nm.

### Claim 27 (depends on 25)

A system as recited in claim 25 wherein the source of diagnostic light includes a slit lamp illuminator and a filter for passing light of about 485 nm.

### Claim 28 (depends on 27)

A system as recited in claim 27 including a pair of lenses into which an observer looks; and a filter to pass light having a wavelength of 530 nm to the lenses for observation.
